{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:03:32Z","timestamp":1782698612269,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clgc.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T12:45:03Z","timestamp":1526906703000},"page":"369-375.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies"],"prefix":"10.1016","volume":"16","author":[{"given":"Angeline","family":"Denouel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Heutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Escudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Longato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Desrues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Rieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Clarisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-5555","authenticated-orcid":false,"given":"Helene","family":"Castel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabien","family":"Noal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.05.013_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00280-015-2770-3","article-title":"Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives","volume":"76","author":"Minguet","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clgc.2018.05.013_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.purol.2013.09.011","article-title":"Medical treatment of renal cell carcinoma","volume":"23","author":"Guy","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.clgc.2018.05.013_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/pon.3196","article-title":"Brain vulnerability to chemotherapy toxicities","volume":"21","author":"Ahles","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.clgc.2018.05.013_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1634\/theoncologist.2010-0078","article-title":"Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies","volume":"15","author":"Larkin","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.clgc.2018.05.013_bib5","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/annonc\/mdq766","article-title":"Sexual life of male patients with advanced renal cancer treated with angiogenesis inhibitors","volume":"22","author":"Bessede","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2018.05.013_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejca.2012.08.008","article-title":"Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a phase I clinical trial unit of predominantly targeted anticancer drugs","volume":"49","author":"Rouanne","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2018.05.013_bib7","first-page":"659","article-title":"Sexual issues in early and late stage cancer: a review","volume":"18","author":"Mercadante","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clgc.2018.05.013_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the united states: prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2018.05.013_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)60280-3","article-title":"Sexual dysfunction in men and women with endocrine disorders","volume":"369","author":"Bhasin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2018.05.013_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","article-title":"Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview","volume":"20","author":"Huyghe","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.clgc.2018.05.013_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.euf.2016.04.009","article-title":"Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer","volume":"2","author":"Joly","year":"2016","journal-title":"Eur Urol Focus"},{"issue":"Suppl 1","key":"10.1016\/j.clgc.2018.05.013_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.8-suppl_1-5","article-title":"Fatigue and quality of life: lessons from the real world","volume":"8","author":"Flechtner","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.clgc.2018.05.013_bib13","first-page":"58","article-title":"Validation of the French \u2018Multidimensional Fatigue Inventory\u2019 (MFI 20)","volume":"12","author":"Gentile","year":"2003","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.clgc.2018.05.013_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2018.05.013_bib15","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11136-004-5531-z","article-title":"Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patients","volume":"14","author":"Costet","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clgc.2018.05.013_bib16","first-page":"191","article-title":"Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI)","volume":"4","author":"Cella","year":"2006","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.clgc.2018.05.013_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00926230500232909","article-title":"Reliability and construct validity of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14)","volume":"32","author":"Keller","year":"2006","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.clgc.2018.05.013_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1743-6109.2007.00749.x","article-title":"Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction","volume":"5","author":"Abraham","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clgc.2018.05.013_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence, mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.clgc.2018.05.013_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2005.1.523","article-title":"Sexuality and fertility after cancer","author":"Schover","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clgc.2018.05.013_bib21","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1210\/jc.2007-2259","article-title":"Erectile dysfunction in patients with hyper- and hypothyroidism: how common and should we treat?","volume":"93","author":"Krassas","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2018.05.013_bib22","first-page":"729","article-title":"Female sexual dysfunction in women with thyroid disorders","volume":"36","author":"Pasquali","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.clgc.2018.05.013_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/fampra\/18.5.516","article-title":"GPs' views on their management of sexual dysfunction","volume":"18","author":"Humphery","year":"2001","journal-title":"Fam Pract"},{"key":"10.1016\/j.clgc.2018.05.013_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.purol.2013.01.006","article-title":"Questionnaires in sexual medicine","volume":"23","author":"Giuliano","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.clgc.2018.05.013_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijir.3901250","article-title":"Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors","volume":"17","author":"Laumann","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.clgc.2018.05.013_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.purol.2012.11.002","article-title":"Women's arousal disorders","volume":"23","author":"Cour","year":"2013","journal-title":"Prog Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318302866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318302866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:30:02Z","timestamp":1761564602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318302866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1558767318302866"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.05.013","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}